December 15, 2022 01:31 PM ESTUpdated December 19, 06:11 AM
FDA+

'Pro­ject Re­newal': FDA up­dates old­er Genen­tech can­cer drug la­bel

Zachary Brennan

Senior Editor

The FDA to­day said it ap­proved up­dat­ed la­bel­ing for Roche’s can­cer drug Xelo­da (capecitabine) tablets as part of a pi­lot project …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

Pfiz­er look­ing to sell hos­pi­tal drugs unit — re­ports

As­traZeneca CEO reaf­firms com­mit­ment to Chi­na fol­low­ing ex­ec­u­tive's de­ten­tion

'Ex­per­tise is a re­al thing': FDA com­mis­sion­er warns of po­lit­i­cal risk to agency

Mer­ck, As­traZeneca tout Phase 3 win for can­cer-turned-rare dis­ease drug

No­var­tis pays $150M up­front to Schrödinger in new drug deal, ramps up soft­ware use

sponsored

What Will It Take to Re­verse Fi­bro­sis in Pa­tients with Ad­vanced MASH?

A service from the Financial Times